glp-1 receptor agonist antipsychotic weight gain study Antipsychotic-Induced in Severe Mental Illness: Risk Factors and Special Considerations | Current Psychiatry Reports Effect of GLP-1 receptor agonists
Description
Retrieved from Teva Pharmaceutical Industries Ltd
[PubMed ID: 25268763]
R&D and Innovation: Pharmaceutical companies are continuing to invest in the development and innovation of GLP-1RA drugs that should lead to increased efficacy, further use cases and reduced side effects
How Do They Work for Weight Loss
Pharmacodynamics and pharmacokinetics were analyzed per last SAR425899 dose received (0.12 or 0.2 mg)
What are Zepbound, Semaglutide GLP-1, and Wegovy approved for
